Jointown Pharmaceutical provides significant guarantees for subsidiaries

As of September 30, 2025, Jointown Pharmaceutical Group Co., Ltd. has provided guarantees totaling 2,895,749.72 million yuan for its 51 subsidiaries, including wholly-owned and controlled entities. This amount represents 106.29% of the company's net assets as of its latest audited period (December 31, 2024). The guarantees are predominantly for subsidiaries with an asset-liability ratio exceeding 70%.

The guarantees, including newly added amounts of 345,350.00 million yuan, are primarily for comprehensive credit facilities and other business operations with banks and financial institutions. The company maintains control over the guaranteed entities, which are reported to be in good operational health, and their financing is centrally managed, mitigating potential risks. No overdue guarantees were reported.

The board of directors approved these guarantees, deeming them necessary and reasonable for the daily operations and long-term development of the group. The company explicitly stated that it has not provided guarantees for its controlling shareholders or related parties.